Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
Clinical trial NCT03202667 · COMPLETED
Trial details
- NCT number
- NCT03202667
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2021-08-26
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.